Status:
COMPLETED
PFAS Exposure and Immune Response to Vaccination in Adults
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Innate Inflammatory Response
Vaccination
Eligibility:
All Genders
18-89 years
Phase:
PHASE4
Brief Summary
This clinical trial aims to investigate how exposure to Perfluorononanoic acid (PFNA), a type of per- and polyfluoroalkyl substance (PFAS), affects the immune response to the standard tetanus and diph...
Eligibility Criteria
Inclusion
- Participated in the Paulsboro PFAS Health Study
- Provided a blood sample for the Paulsboro PFAS Health Study
- Weigh at least 110 pounds
Exclusion
- Currently Pregnant
- History of difficult blood draws
- History of adverse reaction to prior vaccinations
- Currently taking immune suppressants
- Recent dental surgery or dental procedure within 4 weeks of starting study
- Had a Td booster in the past 10 years
Key Trial Info
Start Date :
November 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06588530
Start Date
November 4 2024
End Date
January 8 2025
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EOHSI Paulsboro Office
Paulsboro, New Jersey, United States, 08066